Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Pancreatic lipase (substance) |
Is a |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hepatic triglyceride lipase (substance) |
Is a |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acid lipase |
Is a |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ceramidase |
Is a |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sphingomyelinase |
Is a |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phospholipase (substance) |
Is a |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lipoprotein lipase |
Is a |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lipase preparation |
Is a |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing triacylglycerol lipase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 12000unt/4000unt/12000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 16600unt/5000unt/18750unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 20000unt/4500unt/25000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 20000unt/5000unt/20000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 25000unt/4000unt/25000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 30000unt/10000unt/30000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 30000unt/8000unt/30000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 30000unt/8000unt/30000unt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 3000unt/2400unt/3000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 33200unt/10000unt/37500unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 39000unt/12000unt/39000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 40000unt/8000unt/45000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 48000unt/16000unt/48000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 56000unt/20000unt/44000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 58500unt/18000unt/58500unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 6000unt/16000unt/6000unt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 65000unt/20000unt/65000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 66400unt/20000unt/75000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 664400unt/20000unt/75000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 70000unt/16800unt/70000unt powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 8000unt/30000unt/30000unt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase, pancreatic + protease, pancreatic 12500unt/1000unt/12500unt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase, pancreatic + protease, pancreatic 65000unt/20000unt/65000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing amylase and substance with protease mechanism of action and triacylglycerol lipase |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase- and pancrelipase- and triacylglycerol lipase-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pancrelipase (amylase;lipase 94.3mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pancrelipase (amylase;lipase 210.33mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pancrelipase, amylase:lipase 346.86mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pancrelipase, amylase:lipase 312.17mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pancrelipase, amylase:lipase 184.84mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pancrelipase, amylase:lipase 4500unit capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pancrelipase (amylase;lipase 183.49mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pancrelipase (amylase;lipase 278.72% capsule (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pancrelipase (amylase;lipase 62.81% (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pancrelipase (amylase;lipase 62.81% capsule (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sphingomyelin phosphodiesterase (substance) |
Is a |
False |
Lipase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|